Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk

In clinical trials with binary endpoints, the required sample size does not depend only on the specified type I error rate, the desired power and the treatment effect but also on the overall event rate which, however, is usually uncertain. The internal pilot study design has been proposed to overcom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pobiruchin, Monika (VerfasserIn) , Kieser, Meinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 02 Jan 2013
In: Communications in statistics. Simulation and computation
Year: 2013, Jahrgang: 42, Heft: 7, Pages: 1643-1653
ISSN:1532-4141
DOI:10.1080/03610918.2012.674595
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/03610918.2012.674595
Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/abs/10.1080/03610918.2012.674595
Volltext
Verfasserangaben:Monika Pobiruchin & Meinhard Kieser

MARC

LEADER 00000caa a22000002c 4500
001 178017800X
003 DE-627
005 20220820085228.0
007 cr uuu---uuuuu
008 211203s2013 xx |||||o 00| ||eng c
024 7 |a 10.1080/03610918.2012.674595  |2 doi 
035 |a (DE-627)178017800X 
035 |a (DE-599)KXP178017800X 
035 |a (OCoLC)1341434533 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pobiruchin, Monika  |d 1986-  |e VerfasserIn  |0 (DE-588)1140146688  |0 (DE-627)898268486  |0 (DE-576)493683437  |4 aut 
245 1 0 |a Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk  |c Monika Pobiruchin & Meinhard Kieser 
264 1 |c 02 Jan 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.12.2021 
520 |a In clinical trials with binary endpoints, the required sample size does not depend only on the specified type I error rate, the desired power and the treatment effect but also on the overall event rate which, however, is usually uncertain. The internal pilot study design has been proposed to overcome this difficulty. Here, nuisance parameters required for sample size calculation are re-estimated during the ongoing trial and the sample size is recalculated accordingly. We performed extensive simulation studies to investigate the characteristics of the internal pilot study design for two-group superiority trials where the treatment effect is captured by the relative risk. As the performance of the sample size recalculation procedure crucially depends on the accuracy of the applied sample size formula, we firstly explored the precision of three approximate sample size formulae proposed in the literature for this situation. It turned out that the unequal variance asymptotic normal formula outperforms the other two, especially in case of unbalanced sample size allocation. Using this formula for sample size recalculation in the internal pilot study design assures that the desired power is achieved even if the overall rate is mis-specified in the planning phase. The maximum inflation of the type I error rate observed for the internal pilot study design is small and lies below the maximum excess that occurred for the fixed sample size design. 
650 4 |a 62K99 
650 4 |a 62P10 
650 4 |a Adaptive design 
650 4 |a Binomial distribution 
650 4 |a Internal pilot study design 
650 4 |a Relative risk 
650 4 |a Sample size estimation 
650 4 |a Sample size reestimation 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
773 0 8 |i Enthalten in  |t Communications in statistics. Simulation and computation  |d London : Taylor & Francis, 2001  |g 42(2013), 7, Seite 1643-1653  |h Online-Ressource  |w (DE-627)270131140  |w (DE-600)1476872-0  |w (DE-576)104344687  |x 1532-4141  |7 nnas  |a Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk 
773 1 8 |g volume:42  |g year:2013  |g number:7  |g pages:1643-1653  |g extent:11  |a Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk 
856 4 0 |u https://doi.org/10.1080/03610918.2012.674595  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.tandfonline.com/doi/abs/10.1080/03610918.2012.674595  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211203 
993 |a Article 
994 |a 2013 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 2  |y j 
998 |g 1140146688  |a Pobiruchin, Monika  |m 1140146688:Pobiruchin, Monika  |p 1  |x j 
999 |a KXP-PPN178017800X  |e 4013245094 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Monika Pobiruchin & Meinhard Kieser"]},"relHost":[{"id":{"issn":["1532-4141"],"zdb":["1476872-0"],"eki":["270131140"]},"recId":"270131140","titleAlt":[{"title":"Communications in statistics / Simulation and computation"},{"title":"Simulation and computation"}],"part":{"volume":"42","pages":"1643-1653","extent":"11","year":"2013","issue":"7","text":"42(2013), 7, Seite 1643-1653"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative riskCommunications in statistics. Simulation and computation","language":["eng"],"pubHistory":["11.1982 -"],"title":[{"partname":"Simulation and computation","title":"Communications in statistics","title_sort":"Communications in statistics"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Taylor & Francis ; Dekker","dateIssuedDisp":"2001-","publisherPlace":"London ; New York, NY","dateIssuedKey":"2001"}],"note":["Gesehen am 17.08.11"]}],"id":{"doi":["10.1080/03610918.2012.674595"],"eki":["178017800X"]},"recId":"178017800X","note":["Gesehen am 03.12.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"02 Jan 2013","dateIssuedKey":"2013"}],"title":[{"title":"Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk","title_sort":"Sample size calculation and blinded sample size recalculation in clinical trials where the treatment effect is measured by the relative risk"}],"person":[{"display":"Pobiruchin, Monika","given":"Monika","family":"Pobiruchin","role":"aut"},{"role":"aut","given":"Meinhard","family":"Kieser","display":"Kieser, Meinhard"}]} 
SRT |a POBIRUCHINSAMPLESIZE0220